~~<i id='483B7A9EDB'><strike id='483B7A9EDB'><tt id='483B7A9EDB'><pre id='483B7A9EDB'></pre></tt></strike></i>~~

Home» comprehensive» focus

focus

author：Wikipedia 2025-09-29 04:18:45 Page View：39

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bill would allow buprenorphine prescription for addiction via telehealth
Next article： In age of alternative facts, a scholarly course on calling out crap

explore

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

FILE-Myanmar'sleaderAungSanSuuKyi,left,attendsthebilateralmeetingwithChinesePresidentXiJinpingatthep

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Condition critical? Britain's beloved but battered National Health Service turns 75

Britain'sPrimeMinisterRishiSunakspeaks,duringtheNHSanniversaryceremonyatWestminsterAbbey,partofthehe